Literature DB >> 2549154

Increased levels of a humoral digitalis-like factor in deoxycorticosterone acetate-induced hypertension in the pig.

J M Hamlyn1.   

Abstract

Plasma levels of an endogenous digitalis-like factor (EDLF) and atrial peptides were followed in pigs confined to metabolic cages during the development of deoxycorticosterone acetate (DOCA)-induced hypertension. During the first 2 days of DOCA treatment, urinary sodium excretion decreased and the plasma levels of renin and atrial peptide fell significantly. During this period, plasma levels of EDLF increased greater than 30-fold from a baseline of less than 0.25 to 9.72 nmol ouabain equivalents/l. Between days 2 and 5 of DOCA treatment, urinary sodium returned to pre-DOCA levels ('mineralocorticoid escape') and during this period significant increases of atrial peptide and mean arterial pressure (MAP) and a decrease in EDLF were found. Following mineralocorticoid escape there was a secondary rise in levels of EDLF and atrial peptide and both phenomena correlated with MAP (EDLF, r = 0.87, P less than 0.05; atrial peptide, r = 0.9, P less than 0.05) and with each other (r = 0.96, P less than 0.05) over a 20-day period. Acute expansion of extracellular fluid volume before DOCA elicited significant increments in plasma EDLF and atrial peptide. Volume loading during chronic DOCA treatment increased plasma EDLF significantly whereas no response of atrial peptide was detected. These results suggest that DOCA affects the reactivity of mechanisms involved in the perception of and/or response to acute changes in volume status. However, neither EDLF nor atrial peptide appear to be viable candidates as direct mediators of mineralocorticoid escape. Finally, the nature of the changes found in EDLF and atrial peptide levels during DOCA treatment suggest that these factors are involved in the long-term control of blood pressure in this model of low renin hypertension.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549154     DOI: 10.1677/joe.0.1220409

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  8 in total

1.  Renovascular hypertension using a modified two-kidney, one-clip approach in mice is not dependent on the α1 or α2 Na-K-ATPase ouabain-binding site.

Authors:  John N Lorenz; Valerie M Lasko; Michelle L Nieman; Thomas Damhoff; Vikram Prasad; William H Beierwaltes; Jerry B Lingrel
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-01

Review 2.  Long-term blood pressure control: is there a set-point in the brain?

Authors:  Yasuhiro Nishida; Megumi Tandai-Hiruma; Takehito Kemuriyama; Kohsuke Hagisawa
Journal:  J Physiol Sci       Date:  2012-05       Impact factor: 2.781

3.  Identification and characterization of a ouabain-like compound from human plasma.

Authors:  J M Hamlyn; M P Blaustein; S Bova; D W DuCharme; D W Harris; F Mandel; W R Mathews; J H Ludens
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 4.  Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.

Authors:  Lesley A Graham; Anna F Dominiczak; Nicholas R Ferreri
Journal:  Physiol Genomics       Date:  2017-04-07       Impact factor: 3.107

Review 5.  How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.

Authors:  Mordecai P Blaustein; Frans H H Leenen; Ling Chen; Vera A Golovina; John M Hamlyn; Thomas L Pallone; James W Van Huysse; Jin Zhang; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

6.  DOCA-salt hypertension does not require the ouabain-sensitive binding site of the α2 Na,K-ATPase.

Authors:  John N Lorenz; Naomi Oshiro; Elizabeth L Loreaux; Jerry B Lingrel
Journal:  Am J Hypertens       Date:  2012-01-19       Impact factor: 2.689

Review 7.  The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.

Authors:  Hakuo Takahashi; Masamichi Yoshika; Yutaka Komiyama; Masato Nishimura
Journal:  Hypertens Res       Date:  2011-08-04       Impact factor: 3.872

8.  Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans.

Authors:  Y Al-Solaiman; A Jesri; Y Zhao; J D Morrow; B M Egan
Journal:  J Hum Hypertens       Date:  2009-04-30       Impact factor: 3.012

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.